10.86
price down icon10.49%   -1.26
after-market Dopo l'orario di chiusura: 10.86
loading

Mesoblast Ltd Adr Borsa (MESO) Ultime notizie

pulisher
Jun 11, 2025

Mesoblast Maintains Momentum With FDA on Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure and Label Extension for Ryoncil® in Adults With GvHD - GlobeNewswire Inc.

Jun 11, 2025
pulisher
May 06, 2025

All Markets & Instruments Available to Trade - Capital.com

May 06, 2025
pulisher
Mar 30, 2025

Mesoblast (ASX:MSB) Secures Medicaid Agreement for Ryoncil® - thecapitalclub.com.au

Mar 30, 2025
pulisher
Mar 20, 2025

UPDATED: Your guide to February Reporting Season 2020 - Morningstar.com.au

Mar 20, 2025
pulisher
Mar 03, 2025

21 Best-Performing Small-Cap Stocks for March 2025 - NerdWallet

Mar 03, 2025
pulisher
Feb 09, 2025

Why Mesoblast Ltd ADR (NASDAQ: MESO) Is Worth Including On Your Watchlist - Marketing Sentinel

Feb 09, 2025
pulisher
Feb 06, 2025

The 98.76% Simple Moving Average of Mesoblast Ltd ADR’s (MESO) Stock in the Past 200 Days - The News Heater

Feb 06, 2025
pulisher
Feb 01, 2025

Mesoblast Ltd ADR (NASDAQ:MESO) Shares Are Up 10.24 Percent In A Week – But Can The Gains Continue? - Marketing Sentinel

Feb 01, 2025
pulisher
Jan 31, 2025

ASX Lunch Wrap: ASX and gold reset record highs; but Origin cuts its LNG forecast - Stockhead

Jan 31, 2025
pulisher
Jan 10, 2025

Why are Mesoblast shares in a trading halt? - The Motley Fool Australia

Jan 10, 2025
pulisher
Jan 09, 2025

Mesoblast Limited Initiates Trading Halt Pending Financing Announcement - TipRanks

Jan 09, 2025
pulisher
Jan 08, 2025

ASX December health sector winners… and a 91pc drop for a trial-flopped stock - Stockhead

Jan 08, 2025
pulisher
Jan 03, 2025

MESO Stock Surges 80% In A Month After FDA Approval Of GVHD Drug - Barchart

Jan 03, 2025
pulisher
Jan 02, 2025

Mesoblast (NASDAQ:MESO) Shares Gap UpWhat's Next? - MarketBeat

Jan 02, 2025
pulisher
Dec 31, 2024

ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead

Dec 31, 2024
pulisher
Dec 30, 2024

What Analysts Think About TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP)’s Potential Raise - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

NIO Inc ADR (NYSE: NIO) Stock Forecast: Could Pass $8 In A Year - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

If You Don’t Buy Safe Pro Group Inc (NASDAQ: SPAI) Now, You’ll Regret It Later - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

Tempest Therapeutics Inc (NASDAQ: TPST) Investors Should Be Worried About This. - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

Mesoblast Stock Soars to 52-Week High, Hits $19.15 - Investing.com

Dec 30, 2024
pulisher
Dec 30, 2024

Here’s Why Lineage Cell Therapeutics Inc (AMEX: LCTX) Is An Attractive Investment Right Now - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

No Stopping Editas Medicine Inc (NASDAQ: EDIT)’s Stock Plunged? - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

What Do Analysts Think About Therealreal Inc’s (NASDAQ:REAL) Future? - Stocks Register

Dec 30, 2024
pulisher
Dec 26, 2024

What Awaits These 4 Biotech Stocks That More Than Doubled In 2024 - Barchart

Dec 26, 2024
pulisher
Dec 23, 2024

Mesoblast shares downgraded to hold by Jefferies By Investing.com - Investing.com South Africa

Dec 23, 2024
pulisher
Dec 20, 2024

Why the Mesoblast share price is diving 18% after an FDA win - The Motley Fool Australia

Dec 20, 2024
pulisher
Dec 19, 2024

Mesoblast share price rockets 30% on big US FDA news - The Motley Fool Australia

Dec 19, 2024
pulisher
Dec 16, 2024

Mesoblast stock soars to 52-week high, hits $12.21 - Investing.com

Dec 16, 2024
pulisher
Dec 03, 2024

Mesoblast Stock Soars to 52-Week High, Hits $12.19 - Investing.com

Dec 03, 2024
pulisher
Nov 13, 2024

Mesoblast stock soars to 52-week high, hits $11.1 - Investing.com

Nov 13, 2024
pulisher
Oct 08, 2024

JPMorgan Takes Substantial Stake in Mesoblast Ltd - TipRanks

Oct 08, 2024
pulisher
Sep 30, 2024

Mesoblast to raise $50m from top shareholder for product launch - Capital Brief

Sep 30, 2024
pulisher
Jul 22, 2024

Mesoblast: Rolling The Dice On Cellular Medicines (NASDAQ:MESO) - Seeking Alpha

Jul 22, 2024
pulisher
Apr 26, 2024

Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners - Stockhead

Apr 26, 2024
pulisher
Mar 24, 2024

11 Best ASX Stocks To Buy Now - Yahoo Finance

Mar 24, 2024
pulisher
Feb 12, 2024

symbol__ Stock Quote Price and Forecast - CNN

Feb 12, 2024
pulisher
Feb 05, 2024

10 Best Australian Stocks To Buy - Yahoo Finance

Feb 05, 2024
pulisher
Nov 30, 2022

Australia stocks higher at close of trade; S&P/ASX 200 up 0.43% - Investing.com

Nov 30, 2022
pulisher
Mar 23, 2022

Philip R. Krause, M.D., Former FDA Deputy Chief For Vaccines, Joins Mesoblast Board - Barchart

Mar 23, 2022
pulisher
Oct 02, 2020

ASX dives as Trump tests COVID positive - The Australian

Oct 02, 2020
pulisher
Aug 14, 2020

The Daily Biotech Pulse: Adcom Rules In Favor Of Mesoblast, CureVac IPO, Novavax Clinches UK COVID-19 Vaccine Deal - Yahoo Finance

Aug 14, 2020
pulisher
May 11, 2016

Advantage: Australia. Biotechs Surge Ahead in Regenerative Medicine and Immuno-Oncology - streetwisereports.com

May 11, 2016
pulisher
Apr 01, 2016

6 ASX BioTechs Trading on the NASDAQ - TheBull.com.au

Apr 01, 2016
$20.44
price down icon 1.38%
$36.19
price up icon 0.93%
$22.62
price up icon 6.04%
$98.23
price up icon 0.60%
$108.26
price up icon 0.47%
biotechnology ONC
$244.32
price down icon 0.49%
Capitalizzazione:     |  Volume (24 ore):